AI filing briefs · archive
Every 8-K brief, with filters
The whole archive: 33,711 AI briefs of material SEC Form 8-K filings by 4,788 companies: 2,325 written within three weeks of the filing (filed since Oct 19, 2026) and 31,386 written later, for past filings. Pick a month, or filter by date, 8-K item, tone, impact, topic or ticker.
Briefs on record33,711every one kept
Companies4,788with at least one brief
Recent filings2,325filed since Oct 19, 2026
Past filings31,386written later, in Nov 2026
Upland Software entered a Dividend Waiver Agreement with Ulysses Aggregator, LP, an affiliate of HGGC and holder of all 115,000 Series A Convertible Preferred shares, under which dividend accrual on the preferred stock is waived for an indefinite period effective October 1, 2026. The company expects the waiver to improve net income attributable to common stockholders and per-share results beginning in the fourth quarter of 2026, and the filing gives no dollar amount for the waived dividends.
- Ulysses Aggregator, LP, an affiliate of HGGC, holds all 115,000 outstanding Series A Preferred shares.
- Series A dividends accrue at 4.5% per year, paid in kind; waiver is effective October 1, 2026.
- Waived dividends are permanently forgiven, even if the waiver is revoked by a majority of Series A holders on 30 days' notice.
- Upland expects the full quarterly benefit beginning in the fourth quarter of 2026.
Read the filing on SEC.gov ↗
TechPrecision and its subsidiaries Ranor and Stadco entered a $10.0 million credit agreement with Rosenthal & Rosenthal on November 3, 2026, and used the proceeds to repay the prior Beacon Bank & Trust loan agreement. The facility includes a revolving line of up to $5.0 million and two term loans, and it requires a minimum quarterly tangible net worth of $5.5 million. The company also said it may be unable to file its Form 10-Q for the period ended September 30, 2026 on time.
- Facility includes a $5.0 million revolving line, a $1.5 million three-year term loan and a $3.5 million five-year term loan, secured by substantially all personal property and a first mortgage on Ranor's Westminster, Massachusetts facility
- Prior Beacon Bank & Trust loan agreement was terminated and repaid in full on November 3, 2026; closing costs were approximately $0.6 million.
- Company issued 25,000 shares of common stock to the broker that introduced the lender.
- Management expects the financing to alleviate the substantial doubt about going concern; tangible net worth was $7.6 million as of June 30, 2026 against the $5.5 million covenant.
Read the filing on SEC.gov ↗
On November 6, 2026, U.S. GoldMining agreed to sell 408,163 common shares at $4.90 each to an institutional investor in a registered direct offering. Gross proceeds are expected to be about $2.0 million before offering expenses, with closing expected on or about November 9, 2026. The company plans to use the net proceeds for working capital and general corporate purposes.
- Shares offered: 408,163 common shares at $4.90 per share
- Expected gross proceeds: approximately $1,999,998.70 before offering expenses
- Offering made under an effective Form S-3 shelf registration (File No. 333-279435) and a prospectus supplement dated November 6, 2026
- Expected closing on or about November 9, 2026, subject to customary conditions
Read the filing on SEC.gov ↗
iSpecimen Inc. sold 500 shares of Series D Convertible Preferred Stock to accredited investors for aggregate gross proceeds of $400,000, closing on or about November 6, 2026. The preferred stock is convertible into common stock at a floor price of $0.1616 and can lead to dilution of up to 1,157,223 shares, or 19.99% of shares outstanding, unless stockholders approve the issuance under Nasdaq rules.
- Gross proceeds of $400,000 from 500 Series D shares priced at $800 per share, with a $1,000 stated value per share
- Series D accrues 8% annual cumulative dividends and converts at the greater of 85% of the prior-day closing price or a $0.1616 floor
- Conversion share cap of 1,157,223 shares, or 19.99% of 5,789,013 common shares outstanding, until stockholder approval under Nasdaq Rule 5635(d)
- Placement agent E.F. Hutton & Co. receives a 4.0% cash fee and 1.0% expense allowance; directors and executive officers agreed to 90-day lock-ups
Read the filing on SEC.gov ↗
UWM Holdings Corporation announced the final subscription price for its rights offering of up to 200,000,000 Class A common shares: $2.00 per share. The price is the greater of $2.00 and 85% of the 10-day volume-weighted average NYSE sales price ending November 9, 2026, so the $2.00 floor applied. Subscription rights expire at 5:00 p.m. Eastern Time on November 12, 2026, unless extended.
- Final subscription price is $2.00 per share, the greater of $2.00 and 85% of the 10-day volume-weighted average price ending November 9, 2026.
- The rights offering covers up to 200,000,000 shares of Class A common stock.
- Subscription rights expire at 5:00 p.m. Eastern Time on November 12, 2026, unless extended.
- Exercised rights can be withdrawn until 5:00 p.m. Eastern Time on November 10, 2026, unless the offering is extended; the company may amend, withdraw or terminate the offering with consent of the Backstop Purchasers.
Read the filing on SEC.gov ↗
Reed's closed a private placement on November 9, 2026, issuing common stock to its majority stockholder, D&D Source of Life Holding, Ltd., for approximately $10.0 million in gross proceeds before offering expenses. The proceeds satisfied a requirement under the company's Senior Secured Loan and Security Agreement, as amended, to receive at least $10.0 million in cash equity contributions by November 20, 2026. The filing does not state the number of shares issued.
- Issued common stock to majority stockholder D&D Source of Life Holding, Ltd. on November 9, 2026
- Aggregate gross proceeds of approximately $10.0 million, before offering expenses
- Met the loan agreement's requirement of at least $10.0 million in cash equity contributions due by November 20, 2026
- Purchase Agreement was entered into October 28, 2026; its form was filed as Exhibit 10.1 to the November 3, 2026 8-K
Read the filing on SEC.gov ↗
American Tower priced three registered senior unsecured note offerings totaling $1.5 billion on November 9, 2026. The notes are fungible with existing notes issued on September 14, 2026, and expected net proceeds are $1,474.9 million, which the company intends to use to repay borrowings under its $6.0 billion revolving credit facility and for general corporate purposes.
- 2031 notes: $450.0 million at a 5.300% interest rate, priced at 99.387% of face value
- 2033 notes: $500.0 million at a 5.560% interest rate, priced at 99.369% of face value
- 2036 notes: $550.0 million at a 5.750% interest rate, priced at 98.986% of face value
- Expected net proceeds of $1,474.9 million, to repay revolver borrowings and for general corporate purposes
Read the filing on SEC.gov ↗
On November 9, 2026, Humana Inc. announced cash tender offers for eight series of its outstanding senior notes, with an aggregate purchase cap of $1.5 billion excluding accrued coupon payments. The offers expire at 5:00 p.m. New York City time on November 16, 2026, with settlement expected November 18, 2026. The filing is a debt management action and does not state its effect on earnings or guidance.
- Aggregate purchase cap of $1.5 billion, excluding accrued coupon payments, subject to proration and acceptance priority levels
- Series cap of $800 million on the 5.375% Senior Notes due 2031
- Offers expire 5:00 p.m. New York City time on November 16, 2026; pricing is set on the same day at 3:00 p.m.
- Expected settlement date is November 18, 2026; dealer managers include Barclays, BofA Securities, PNC and U.S. Bancorp
Read the filing on SEC.gov ↗
On November 9, 2026, Equinix Europe 2 Financing Corporation, an indirect wholly-owned subsidiary, issued €2.5 billion of senior notes in four series, fully and unconditionally guaranteed by Equinix, Inc. The notes carry fixed coupons from 4.150% to 5.450% and mature between 2028 and 2038, and Equinix intends to allocate the proceeds to eligible green projects. For shareholders, this adds debt to the company's balance sheet, though the filing does not compare it with existing debt levels.
- €650 million 4.150% notes due November 9, 2028, and €700 million 4.800% notes due February 15, 2033
- €500 million 5.100% notes due November 9, 2035, and €650 million 5.450% notes due November 9, 2038
- Net proceeds are intended for eligible green projects; pending allocation, they may be held in cash or used to repay existing borrowings
- Equinix hedged part of the interest rate risk on the 2035 and 2038 notes, with effective all-in rates of 4.91% and 5.42%
Read the filing on SEC.gov ↗
Orchestra BioMed sold 15,000,000 shares of common stock at $5.00 per share under an underwritten public offering priced November 5, 2026, and the offering closed November 9, 2026. The underwriters' 2,250,000-share option was exercised in full on November 6, 2026, and the filing puts gross proceeds at approximately $86.3 million before underwriting discounts and expenses, with the company citing the AVIM Therapy program, the BACKBEAT pivotal trial, and the Virtue SAB program as intended uses.
- Offering: 15,000,000 shares at $5.00 per share, priced November 5, 2026, with Piper Sandler and TD Securities as representatives of the underwriters
- Underwriters' 30-day option for 2,250,000 additional shares was exercised in full on November 6, 2026
- Gross proceeds of approximately $86.3 million before underwriting discounts, commissions and other offering expenses; offering closed November 9, 2026
- Stated uses: AVIM Therapy program, BACKBEAT global pivotal trial, Virtue SAB program and its coronary in-stent restenosis trial, other product candidates, and working capital
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.